Photys Therapeutics Announces Research Collaboration with Novo Nordisk to Develop Induced Proximity PHICS Technology for Cardiometabolic Diseases
December 18, 2024 07:30 ET
|
Photys Therapeutics, Incl
Photys and Novo Nordisk established a research collaboration to discover a new class of medicine for cardiometabolic diseases.
Novo Nordisk A/S - share repurchase programme
December 16, 2024 07:52 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 16 December 2024 – On 11 November 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
Novo Nordisk invests DKK 8.5 billion in new production facility in Odense, Denmark
December 16, 2024 01:29 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 16 December 2024 – Today, Novo Nordisk announced plans to invest 8.5 billion Danish kroner to establish a completely new production facility in Odense, Denmark. The investment marks...
Defiance Launches NVOX, the First 2X Leveraged Single-Stock ETF on Novo Nordisk
December 03, 2024 06:00 ET
|
Defiance ETFs
Defiance Launches NVOX, the First 2X Leveraged Single-Stock ETF on Novo Nordisk
Tiziana Life Sciences Announces Positive Results from Ozempic and Nasal Anti-CD3 Combination Study
October 30, 2024 08:30 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
Novo Nordisk A/S – Share repurchase programme
October 07, 2024 06:44 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 7 October 2024 – On 7 August 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
Novo Nordisk A/S – Share repurchase programme
September 30, 2024 07:02 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 30 September 2024 – On 7 August 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
Novo Nordisk A/S - share repurchase programme
September 09, 2024 09:55 ET
|
Novo Nordisk A/S
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 9 September 2024 – On 7 August 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No...
Novo Nordisk A/S – Share repurchase programme
August 12, 2024 08:31 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 12 August 2024 – On 7 August 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
Novo Nordisk A/S – Share repurchase programme
July 29, 2024 07:05 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 29 July 2024 – On 6 May 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16...